Kenvue Inc.

Kenvue Inc. operates as a pure-play consumer health company focused on personal healthcare and everyday wellness. The company develops and markets products across three primary business segments: Self Care, Skin Health and Beauty, and Essential Health. Its Self Care portfolio features over-the-counter medications and remedies for cough, cold, allergies, and pain management under brands such as Tylenol, Motrin, Benadryl, and Nicorette. The Skin Health and Beauty division provides science-backed dermatological formulations for face, body, and hair care, including Aveeno and Neutrogena. Through Essential Health, it supplies oral hygiene, baby care, and wound care items such as Listerine, Johnson's, and BAND-AID. The company serves global consumers, partnering directly with healthcare professionals and distributing products through retailers, pharmacies, and digital channels.

The company markets its personal care and wellness offerings across more than 165 countries worldwide, covering North America, Latin America, Europe, the Middle East, Africa, and the Asia-Pacific region. Kenvue is incorporated in Delaware, United States.

Summary of the business section of Kenvue's latest annual report, written by StockData.

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

“As of December 28, 2025, we had approximately 22,000 employees, with approximately 23% located in North America, 28% in EMEA, 30% in APAC, and 19% in LATAM.”